Clinical Trial Highlights - GLP-1 agonists

Kevin McFarthing; Danielle Larson; Tanya Simuni

doi:10.3233/JPD-200002

Clinical Trial Highlights - GLP-1 agonists

Kevin McFarthing, Danielle Larson, Tanya Simuni

Neurology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	355-368
Number of pages	14
Journal	Journal of Parkinson's disease
Volume	10
Issue number	2
DOIs	https://doi.org/10.3233/JPD-200002
State	Published - 2020

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.3233/JPD-200002

Cite this

@article{02914853e79a4caea0335d3cae648310,

title = "Clinical Trial Highlights - GLP-1 agonists",

author = "Kevin McFarthing and Danielle Larson and Tanya Simuni",

year = "2020",

doi = "10.3233/JPD-200002",

language = "English (US)",

volume = "10",

pages = "355--368",

journal = "Journal of Parkinson's Disease",

issn = "1877-7171",

publisher = "IOS Press",

number = "2",

}

TY - JOUR

T1 - Clinical Trial Highlights - GLP-1 agonists

AU - McFarthing, Kevin

AU - Larson, Danielle

AU - Simuni, Tanya

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85083072200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083072200&partnerID=8YFLogxK

U2 - 10.3233/JPD-200002

DO - 10.3233/JPD-200002

M3 - Article

C2 - 32250322

AN - SCOPUS:85083072200

SN - 1877-7171

VL - 10

SP - 355

EP - 368

JO - Journal of Parkinson's Disease

JF - Journal of Parkinson's Disease

IS - 2

ER -

Clinical Trial Highlights - GLP-1 agonists

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this